DXSP DXS International PLC

Statement re: Further NHS Accreditation

Statement re: Further NHS Accreditation

DXS INTERNATIONAL PLC

(AQSE: DXSP)

Statement Re:  Further NHS Accreditation

DXS International, the digital clinical decision support company, is pleased to announce that on Friday 14 April it received NHS Accreditation for the NHS IM1 Pairing Integration API which provides read and write access to GP patient data throughout the UK.

This important achievement alleviates DXS’ dependency on using the existing commercial integrations provided by the three leading suppliers of primary care patient record systems in the UK. The development will also significantly enhance DXS’ ability to deliver its new ExpertCare Hypertension solution to users such as GPs, nurses and pharmacists throughout the UK, faster, better and more cost effectively.

This 18-month development initiative included building the foundation component of a new cloud based Aios platform which will significantly speed up deployment of various DXS products, automate user workflows and reduce support overhead.

David Immelman, DXS CEO, said “This is an exciting step forward, especially as DXS ExpertCare can help the NHS achieve its new target in England for GP practices to get controlled blood pressure up from 60% to 77% of the 8.5 million hypertensive patients in England which can save thousands of strokes and heart attacks.”

The Directors of DXS International plc accept responsibility for this announcement.

Contacts:

David Immelman      (Chief Executive)

DXS International plc
01252 719800

-systems.co.uk 



Corporate Advisor



 
 
City & Merchant

David Papworth



 
020 7101 7676



 



Corporate Broker



 
 
Hybridan LLP

Claire Louise Noyce



 
020 3764 2341



 

Notes to Editors

About DXS:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.



EN
25/04/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DXS International PLC

Hybridan Team ... (+2)
  • Hybridan Team
  • Jon Levinson

Hybridan Research: DXS International PLC

Good Afternoon, DXS International PLC (AQSE:DXSP) announced Interims to 31 October 2025. We have published research on this which is attached and a snapshot of the research is below.

Hybridan Team ... (+2)
  • Hybridan Team
  • Jon Levinson

Hybridan Small Cap Feast: 28 January 2026

28th January 2026 @HybridanLLP Our daily digest of news from UK Small Caps * A corporate client of Hybridan LLP. ** Potential means Intention to Float (ITF) or similar announcement has been made. ***Arranged by type of listing and date of announcement. ****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication. Dish of the Day Admissions: Following a Reverse Tak...

 PRESS RELEASE

DXS International plc (AQSE: DXSP): Half-year Financial Report

DXS International plc (AQSE: DXSP): Half-year Financial Report DXS INTERNATIONAL PLC (AQSE: DXSP) HALF YEAR RESULTS DXS International plc ("DXS" or the "Company"), the digital clinical decision support company, is pleased to provide shareholders with its unaudited interim results for the half year ending 31 October 2025. H1 2025 Financial highlights: Core recurring revenue model remains resilient. Revenue decreased by 2.6% to £1,684,712 (H1 2024 - £1,730,829) in the six months to 31 October 2025 ("Period"). Administration costs decreased by 5% in the Period (H1 2024 -£87,474)Loss afte...

 PRESS RELEASE

DXS International plc (AQSE: DXSP) Update on Cyber Security Incident

DXS International plc (AQSE: DXSP) Update on Cyber Security Incident 24 December 2025 DXS INTERNATIONAL PLC (AQSE: DXSP) Update on Cyber Security Incident The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, would like to provide an update on the security incident that affected its office servers, which was reported via RNS on 18 December. The incident has been contained, and DXS remains vigilant by implementing additional monitoring and security measures.  The Director...

 PRESS RELEASE

DXS INTERNATIONAL PLC (AQSE: DXSP) Result of AGM

DXS INTERNATIONAL PLC (AQSE: DXSP) Result of AGM 19 December 2025 DXS INTERNATIONAL PLC (AQSE: DXSP) Result of DXS AGM 2025 The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce that all resolutions put to shareholders at the Company's Annual General Meeting ("AGM") held yesterday were duly passed. All resolutions were passed on a poll and the votes received from shareholders on each resolution put to the AGM are set out below. ResolutionVotes For *...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch